C . Allen Pinkham

  • Citations Per Year
Learn More
Since the widespread introduction of the blood test requirement for life insurance, the interpretation of liver function tests (AST, ALT, GGT) has generated intense interest. Elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) have been shown to be associated with primary liver diseases, as well as increased all-cause mortality.(More)
OBJECTIVE To investigate if a mortality differential exists between insurance policyholders with treated hypertension and policyholders who are not under such treatment, where both groups are noted to have the same blood pressure at the time of policy issue. BACKGROUND Hypertension is a known mortality risk factor in the insured and general population.(More)
Obesity assessed by body mass index (BMI) is associated with increased mortality risk, but there is uncertainty about whether BMI is the best way to measure obesity. Waist circumference (WC) has been proposed as a better measure. The Swiss Re BMI/WC Study was conducted to determine whether BMI or WC is a better predictor of future all-cause mortality in a(More)
OBJECTIVES To investigate relationships between serum lipids and all-cause mortality in an insured population issued policies at standard rates using contemporary analytic techniques. BACKGROUND As with other preferred risk factors, differences in lipid profiles can be an important contributor to morbidity and mortality endpoints in the general and(More)
In 2000, five current pro f e s s i o n a l athletes died, the most in one year since 1993. With the media spotlight often on drug and alcohol abuse, violence, and auto accidents among athletes, it’s no surprise that t h e y ’ re often perceived as poor insurance risks— even by many in the business of risk. Life re i n s u rers, for example, often find it(More)
Anticipating that genetic tests designed to determine an individuals predisposition to disease would eventually become commercially available, and recognizing that the results of many of these tests may have mortality implications, in 1994 Lincoln National Reinsurance Companies began developing a methodology that would allow the mortality risk associated(More)
  • 1